Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Korro Bio, Inc. | Director | Common Stock | 195K | $10.9M | $56.00 | Apr 22, 2024 | Indirect |
Intellia Therapeutics, Inc. | Director | Common Stock | 7.29K | $214K | $29.38 | Jun 14, 2022 | Direct |
Spero Therapeutics, Inc. | Director | Stock Option (right to buy) | 7.5K | $8.4K | $1.12 | Aug 17, 2021 | Direct |
Ikena Oncology, Inc. | Director | Stock Option (Right to Buy) | 17.5K | Jun 7, 2024 | Direct | ||
Intellia Therapeutics, Inc. | Director | Stock Option (right to buy) | 7.69K | Jun 14, 2022 | Direct | ||
Korro Bio, Inc. | Director | Stock Option (Right to Buy) | 5.19K | Jun 11, 2024 | Direct | ||
Translate Bio, Inc. | Director | Common Stock | 0 | $38.00 | Sep 14, 2021 | Indirect | |
Translate Bio, Inc. | Director | Stock Option (right to buy) | 0 | Sep 14, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KRRO | Korro Bio, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
IKNA | Ikena Oncology, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
KRRO | Korro Bio, Inc. | Apr 22, 2024 | 1 | $1M | 4 | Apr 23, 2024 | Director |
FREQ | Korro Bio, Inc. | Nov 3, 2023 | 3 | $0 | 4 | Nov 7, 2023 | Director |
FREQ | Korro Bio, Inc. | Nov 3, 2023 | 0 | $0 | 3 | Nov 7, 2023 | Director |
IKNA | Ikena Oncology, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
IKNA | Ikena Oncology, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
IKNA | Ikena Oncology, Inc. | Dec 21, 2021 | 1 | $0 | 4 | Dec 23, 2021 | Director |
TBIO | Translate Bio, Inc. | Sep 14, 2021 | 5 | -$78.1M | 4 | Sep 14, 2021 | Director |
SPRO | Spero Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 28, 2021 | 18 | -$73.4M | 4 | Jun 29, 2021 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 23, 2021 | 2 | $0 | 4 | Jun 25, 2021 | Director |
TBIO | Translate Bio, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 11, 2021 | 7 | -$17.6M | 4 | Jun 15, 2021 | Director |
IKNA | Ikena Oncology, Inc. | Mar 30, 2021 | 4 | $1.61M | 4 | Dec 14, 2021 | Director |